Terns Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Kuriakose Emil unloaded Company’s shares for reported $25607.0 on Jan 02 ’25. In the deal valued at $5.71 per share,4,481 shares were sold. As a result of this transaction, Kuriakose Emil now holds 54,269 shares worth roughly $0.31 million.
Then, Vignola Mark J. sold 9,059 shares, generating $52,500 in total proceeds. Upon selling the shares at $5.80, the Chief Financial Officer now owns 74,752 shares.
Before that, Vignola Mark J. sold 8,129 shares. Terns Pharmaceuticals Inc shares valued at $46,524 were divested by the Chief Financial Officer at a price of $5.72 per share. As a result of the transaction, Vignola Mark J. now holds 83,811 shares, worth roughly $0.48 million.
Oppenheimer initiated its Terns Pharmaceuticals Inc [TERN] rating to an Outperform in a research note published on October 31, 2024; the price target was $82. A number of analysts have revised their coverage, including Mizuho’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Jefferies began covering TERN with “Buy” recommendation on June 07, 2023. ROTH MKM started covering the stock on May 31, 2023. It rated TERN as “a Buy”.
Price Performance Review of TERN
On Monday, Terns Pharmaceuticals Inc [NASDAQ:TERN] saw its stock fall -0.70% to $5.71. Over the last five days, the stock has lost -1.04%. Terns Pharmaceuticals Inc shares have risen nearly 3.07% since the year began. Nevertheless, the stocks have fallen -14.78% over the past one year. While a 52-week high of $11.40 was reached on 01/06/25, a 52-week low of $4.32 was recorded on 01/02/25. SMA at 50 days reached $6.39, while 200 days put it at $6.99.
Levels Of Support And Resistance For TERN Stock
The 24-hour chart illustrates a support level at 5.57, which if violated will result in even more drops to 5.43. On the upside, there is a resistance level at 5.90. A further resistance level may holdings at 6.09. The Relative Strength Index (RSI) on the 14-day chart is 41.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.34%. Stochastics %K at 19.66% indicates the stock is a buying.
How much short interest is there in Terns Pharmaceuticals Inc?
A steep rise in short interest was recorded in Terns Pharmaceuticals Inc stocks on 2024-12-13, growing by 2.23 million shares to a total of 6.2 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 3.98 million shares. There was a rise of 35.91%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 08, 2023 when BMO Capital Markets began covering the stock and recommended ‘”an Outperform”‘ rating along with a $18 price target.
